Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Mvise AG | C1V | Sep 27, 2024 | 0.45 | +8.25 |
MVV Energie AG | MVV1 | Sep 27, 2024 | 31.20 | -1.27 |
MWB FAIRTRADE WPHDL.NA ON | MWB0 | Sep 27, 2024 | 3.19 | -1.24 |
Mycronic | MLT | Sep 27, 2024 | 34.92 | +1.99 |
Mydecine Innovations Group Inc | 0NF0 | Sep 27, 2024 | 0.00 | 0.00 |
Myer Holdings Ltd | 30M | Sep 27, 2024 | 0.47 | +0.42 |
Myers Industries, Inc. | MJF | Sep 27, 2024 | 12.30 | 0.00 |
MYHEALTHCHECKED LS -,015 | 0I10 | Sep 27, 2024 | 0.13 | -26.32 |
MYHOTELMATCH EO 1,- | 6GD0 | Sep 27, 2024 | 0.36 | -0.56 |
Mynaric ADR | M0YA | Sep 27, 2024 | 1.41 | +16.53 |
MYNARIC AG NA O.N. | M0YN | Sep 27, 2024 | 5.16 | 0.00 |
Mynd.Ai | WK6 | Sep 27, 2024 | 0.76 | -4.43 |
Myomo Inc. | 0M61 | Sep 27, 2024 | 3.29 | -2.81 |
MYR Group, Inc. | MYP | Sep 27, 2024 | 91.00 | +2.82 |
Myriad Genetics, Inc. | MYD | Sep 27, 2024 | 23.40 | -0.85 |
MYRIAD URANIUM CORP. | C3Q | Sep 27, 2024 | 0.25 | -5.93 |
Mytilineos S.A. | MYH | Sep 27, 2024 | 35.32 | +0.86 |
N Brown Group PLC | BGUA | Sep 27, 2024 | 0.28 | +1.45 |
N4 Pharma plc. | 0GO | Sep 27, 2024 | 0.00 | 0.00 |
Naas Technology ADR | 6RE | Sep 27, 2024 | 3.28 | 0.00 |
Nabaltec AG | NTG | Sep 27, 2024 | 14.70 | +1.73 |
Nabors Industries Ltd | NBI1 | Sep 27, 2024 | 55.00 | +0.92 |
Nabtesco Corp. | 3N8 | Sep 27, 2024 | 16.00 | +1.91 |
Nachi-Fujikoshi Corp. | 8UM | Sep 27, 2024 | 19.20 | -0.52 |
Nacon S.A. | 4AW | Sep 27, 2024 | 0.86 | -0.46 |
Nafco Co | 64E | Sep 27, 2024 | 15.10 | -4.43 |
NAGACORP | N9J | Sep 27, 2024 | 0.37 | -0.54 |
Nagambie Resources Limited | P6C | Sep 27, 2024 | 0.01 | +22.22 |
Nagarro SE | NA9 | Sep 27, 2024 | 83.05 | +3.04 |
Nagoya Railroad Co. Ltd | 59V | Sep 27, 2024 | 10.60 | +1.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.